Middleton William D, Teefey Sharlene A, Reading Carl C, Langer Jill E, Beland Michael D, Szabunio Margaret M, Desser Terry S
1 Mallinckrodt Institute of Radiology, Washington University in St. Louis, 510 S Kingshighway Blvd, St. Louis, MO 63110.
2 Department of Diagnostic Radiology, Mayo Clinic, Rochester, MN.
AJR Am J Roentgenol. 2017 Jun;208(6):1331-1341. doi: 10.2214/AJR.16.17613. Epub 2017 Apr 12.
Guidelines for managing thyroid nodules are highly dependent on risk stratification based on sonographic findings. The purpose of this study is to evaluate the risk stratification system used by the American College of Radiology Thyroid Imaging Reporting and Data System (TIRADS).
Patients with thyroid nodules who underwent sonography and fine-needle aspiration were enrolled in a multiinstitutional study. The sonographic nodule features evaluated in the study were composition, echogenicity, margins, and echogenic foci. Images were reviewed by two radiologists who were blinded to the results of cytologic analysis. Nodules were assigned points for each feature, and the points were totaled to determine the final TIRADS level (TR1-TR5). The risk of cancer associated with each point total and final TIRADS level was determined.
A total of 3422 nodules, 352 of which were malignant, were studied. The risk of malignancy was closely associated with the composition, echogenicity, margins, and echogenic foci of the nodules (p < 0.0001, in all cases). An increased aggregate risk of nodule malignancy was noted as the TIRADS point level increased from 0 to 10 (p < 0.0001) and as the final TIRADS level increased from TR1 to TR5 (p < 0.0001). Of the 3422 nodules, 2948 (86.1%) had risk levels that were within 1% of the TIRADS risk thresholds. Of the 474 nodules that were more than 1% outside these thresholds, 88.0% (417/474) had a risk level that was below the TIRADS threshold.
The aggregate risk of malignancy for nodules associated with each individual TIRADS point level (0-10) and each final TIRADS level (TR1-TR5) falls within the TIRADS risk stratification thresholds. A total of 85% of all nodules were within 1% of the specified TIRADS risk thresholds.
甲状腺结节管理指南高度依赖基于超声检查结果的风险分层。本研究的目的是评估美国放射学会甲状腺影像报告和数据系统(TIRADS)所使用的风险分层系统。
对接受超声检查和细针穿刺的甲状腺结节患者进行一项多机构研究。本研究评估的超声结节特征包括成分、回声、边界和回声灶。由两位对细胞学分析结果不知情的放射科医生对图像进行审查。为每个特征给结节打分,将分数相加以确定最终的TIRADS级别(TR1 - TR5)。确定与每个总分及最终TIRADS级别相关的癌症风险。
共研究了3422个结节,其中352个为恶性。恶性风险与结节的成分、回声、边界和回声灶密切相关(所有情况均为p < 0.0001)。随着TIRADS分数级别从0增加到10(p < 0.0001)以及最终TIRADS级别从TR1增加到TR5(p < 0.0001),结节恶性的总体风险增加。在3422个结节中,2948个(86.1%)的风险级别在TIRADS风险阈值的1%范围内。在超出这些阈值1%以上的474个结节中,88.0%(417/474)的风险级别低于TIRADS阈值。
与每个单独的TIRADS分数级别(0 - 10)和每个最终TIRADS级别(TR1 - TR5)相关的结节恶性总体风险落在TIRADS风险分层阈值范围内。所有结节中85%在指定的TIRADS风险阈值的1%范围内。